Regulation On The Prescription Of Medicinal Products

Original Language Title: Verordnung über die Verschreibungspflicht von Arzneimitteln

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$20 per month, or Get a Day Pass for only USD$4.99.

Ordinance on prescription of medicinal products (prescription drug prescription-AMVV)

Non-official table of contents

AMVV

Date of delivery: 21.12.2005

Full Quote:

" The prescription drug prescription of 21. December 2005 (BGBl. 3632), which was last amended by Article 2 of the Regulation of 6 June 2000. March 2015 (BGBl. I p. 278) "

:Last modified by Art. 2 V v. 6.3.2015 I 278

For details, see the Notes

Footnote

(+ + + text evidence from: 1.1.2006 + + +)


for details. has been referred to as Article 1 of the V v. 21.12.2005 I 3632 from the Federal Ministries of Health, Food, Agriculture and Consumer Protection in agreement with the Federal Ministries of Economy and Technology, for the Environment, Nature Conservation and Nuclear Safety and for Health, according to Consultation of the expert committee on prescription, with the approval of the Bundesrat. She's gem. Article 3 (1), first sentence, of this V entered into force on 1 January 2006. unofficial table of contents

§ 1

medicines,
1.
the substances or preparations made in Appendix 1 to this Regulation are or are
2.
the preparations of the substances or preparations of the Appendix 1 are or are
3.
to which the substances and preparations mentioned under number 1 or 2 have been added or
4.
which fall within the scope of § 48 paragraph 1 sentence 1 no. 2 of the German Medicines Act,
may only be used if there is a medical, dental or veterinary medicine. You will be given a prescription (prescription-only medicinal products) unless otherwise specified in the following regulations. Non-official table of contents

§ 2

(1) The prescription must include:
1.
Name, first name, professional title and address of the practice or clinic of the prescribing medical, veterinary or dental person (prescribing person), including a contact telephone number,
2.
date of manufacture,
3.
The name and date of birth of the person for which the medicine is intended
4.
Name of the Medicinal product or active substance, including starch,
4a.
in the case of a medicinal product intended to be manufactured in the pharmacy, the composition by type and the quantity or name of the medicinal product for which subsets are to be dispensed,
5.
pharmaceutical form, provided that the name referred to in point 4 or Number 4a is not unique,
6.
quantity to be dispensed with the prescribed medicinal product,
7.
Instructions for use in pharmaceuticals to be manufactured in pharmacy
8.
Duration the prescription,
9.
in the case of veterinary prescriptions, in addition
a)
the dose per tier and day,
b)
the duration of the application, and
c)
if the medicine is prescribed for use in animals used to produce food, the indication and the waiting time,
and instead of the information given in Number 3, the name of the keeper and the number and type of animals for which the medicinal product is to be used, and in the case of prescriptions for animals used for the production of foodstuffs, the identity of the animals,
10.
the personal signature of the prescribing person or, in the case of prescriptions in electronic form, their qualified electronic signature after the Signature Act.
(1a) prescriptions from the Member States of the European Union, from the States Parties to the Agreement on the European Union, are prescribed by medical or dental prescriptions originating in Germany. The European Economic Area and Switzerland shall, if they have the information referred to in paragraph 1, provide evidence of their authenticity and their exhibition by a qualified medical or dental person. The regulations of § 3a as well as the narcotics presenter ordinance remain unaffected.(1b) A medical or dental prescription issued for the purpose of being awarded in another Member State of the European Union, in a State Party to the Agreement on the European Economic Area or in Switzerland, to be provided in accordance with , it shall contain the following information:
1.
The name, first name, and date of birth of the person for which the Medicine is determined,
2.
Date of manufacture,
3.
Name, first name, and one of the professional qualifications recognized by the prescribing medical or dental person (prescribing person),
4.
address of the person who is responsible for the professional qualification of the person who is responsible for the professional qualification. the prescriber, including the name of the Member State, their telephone number or fax number, indicating the country code and their e-mail address,
5.
handwritten or digital signature of the prescribing person, depending on the medium of the prescribing,
6.
as defined in Article 1 (21) of Directive 2001/83/EC of the European Parliament and of the Council of 6 June 2001. November 2001 on the Community code relating to medicinal products for human use (OJ L 327, 28.12.2001, p. 67), as last amended by Regulation (EC) No 1901/2006 (OJ L 311, 28.11.2006, p. 1), the common name of the medicinal product (international non-proprietary name); the name of a ready-to-use medicinal product may be used where
a)
the prescribed medicine is a biological medicine according to point 3.2.1.1. point (b) of Annex I, part 1 of Directive 2001 /83/EC, or
b)
the prescribing person considers it necessary for medical purposes; in this case, the prescribing shall: a short justification for the use of the medicinal product name
7.
the amount of the prescribed medicinal product to be dispensed, its potency within the meaning of Directive 2001 /83/EC and the pharmaceutical form,
8.
Posology.
(2) Is the prescription for the practical needs of a prescribing person, for a person who is not Hospital, for facilities or subunits of rescue services, for on-board pharmacy of aircraft pursuant to § 1 para. 2 nos. 1 and 2 of the operating regulations for aeronautical equipment of 4. March 1970 (BGBl. 262), as last amended by Article 449 of the Regulation of 29 June 1994. October 2001 (BGBl. 2785), the information referred to in paragraph 1 (3), (7) and (9) shall be replaced by an appropriate endorsement for a veterinary clinic or zoo.(3) The prescription of a medicinal product which is authorised for the purpose of taking an abortion and which is only available in a facility within the meaning of § 13 of the pregnancy conflict law of 27 January 2011. July 1992 (BGBl. 1398), as defined by Article 1 of the Law of 21. August 1995 (BGBl. 1050), the information referred to in paragraph 1 (3) shall be replaced by a statement of the same type.(4) If the quantity of the prescribed medicinal product is not indicated in the case of medicinal products in the ready-to-release package, the smallest package shall be deemed to be prescribed.(5) If the period of validity is not specified, the prescription shall be valid for three months.(6) If the date of birth of the person for which the medicinal product is intended or the information referred to in paragraph 1 (2), (5) or (7) is missing or is incomplete, the pharmacist may, if there is an urgent case, and a consultation with the is not possible to prescribe the prescribing in this respect.(7) Where the prescription of a medicinal product is intended for a hospital in which there is a system for the transmission of a medicinal product for the transmission of data which ensures the prescription by a person who is authorised to prescribe, it shall be sufficient in place of the personal signature referred to in paragraph 1, point 10, the name reproduction of the person who is prescribing the person or, in the case of prescriptions in electronic form, a suitable electronic identification procedure.(8) If the prescription is intended for a hospital, it can also be transmitted exclusively with the aid of a telefax machine. Non-official table of contents

§ 3

The prescription of a medicinal product within the meaning of § 2 para. 3 is in two copies (original and transcript) to create. The original and the copy shall be transmitted to the pharmaceutical company. The copy must be accompanied by the serial numbers of the packages delivered in accordance with section 47a (2) sentence 1 of the German Medicines Act and the date of the submission and the copy thereof with the medicinal product of the institution within the meaning of § 13 of the Pregnancy Conflict Act. The originals remain with the pharmaceutical company. The latter shall keep the originals for a period of five years and shall submit them on request to the competent authority. On the copy of the prescription, the prescribing person shall record the date of receipt and application of the medicinal product as well as the assignment to the concrete patient records in an anonymized form. It shall keep the copies in an orderly manner for five years and shall submit them to the competent authority for inspection at the request of the competent authority. For prescriptions in electronic form, the sentences 1 to 7 shall apply accordingly. Unofficial table of contents

§ 3a

(1) prescription of medicines containing the active substances lenalidomide, pomalidomide, or thalidomide, may only be made on a numbered two-part official form (original and transcript) of the Federal Institute for Medicinal Products and Medical Devices. The forms referred to in the first sentence shall be determined exclusively for prescribtion of the medicinal products referred to in the first sentence.(2) prescriptions referred to in the first sentence of paragraph 1 shall include the confirmation of the medical person that the security measures are complied with in accordance with the current technical information of the relevant final medicinal product, in particular that: if necessary, a pregnancy prevention programme is carried out and that the patient or the patient, prior to the start of the medicinal product treatment, should receive appropriate medical information and the current information on the use of the the corresponding finished medicinal products. In addition, the prescription shall indicate whether treatment is carried out inside or outside the designated areas of application.(3) The maximum quantity of medicinal products prescribed for prescriptions referred to in the first sentence of paragraph 1 may not exceed, in each case, four weeks for women of childbearing potential, otherwise not for twelve weeks.(4) By way of derogation from Section 2 (5), a prescription referred to in the first sentence of paragraph 1 shall be valid for up to six days after the date of its exhibition.(5) The forms referred to in the first sentence of paragraph 1 shall be issued by the Federal Institute for Medicinal Products and Medical Devices on request to the individual medical person against proof of medical examination of the medicine. The requirement must be accompanied by a statement from the doctor that
1.
the medical Information materials for lenalidomide, pomalidomide or thalidomide according to the current specialist information for corresponding ready-to-use medicinal products are available,
2.
the prescription of medicinal products as referred to in the first sentence of paragraph 1 shall comply with all safety measures in accordance with the current technical information of appropriate pre-manufactured medicinal products; and
3.
it has sufficient expertise to prescribe medicinal products as referred to in the first sentence of paragraph 1.
(6) The Federal Institute for Drugs and Medical Devices makes a The model of the form referred to in the first sentence of paragraph 1 shall be publicly known.(7) Pharmacies shall send the copies of the forms referred to in the first sentence of paragraph 1 weekly to the Federal Institute for Medicinal Products and Medical Devices. Non-official table of contents

§ 4

(1) Does not allow the use of a medicinal product subject to medical prescription to be postponed, the prescribing Inform the pharmacist in a suitable manner, in particular by telephone, about the prescription and their contents. The pharmacist has to give certainty about the identity of the prescribing person. The prescribing person shall immediately submit to the pharmacist the prescription in written or electronic form.(2) The prescription shall not require a written or electronic form for the self-use of a person who is prescribing. The second sentence of paragraph 1 shall apply accordingly.(3) The repeated delivery of a medicinal product subject to medical prescription to the same prescription beyond the prescribed quantity shall be inadmissible. Non-official table of contents

§ 5

The prescription shall not apply to medicinal products derived from those contained in Appendix 1 to this Regulation. shall be made, in particular in accordance with the rules of the homeopathic medicinal product, or which consist of mixtures of such substances or preparations of substances, in accordance with homeopathic process technology, if the final concentration of these medicinal products in the finished product does not exceed the fourth decimal potency. These medicinal products may also be mixed with substances and preparations not subject to medical prescription. Non-official table of contents

§ 6

The prescription obligation pursuant to § 48 (1) sentence 1 No. 2 of the German Medicines Act (Medicines Act) shall not apply to medicinal products. which contain neither a substance listed in Appendix 2, its preparation or salt, nor any such substance, preparation or salt thereof. unofficial table of contents

§ 7

(omitted) unofficial Table of Contents

§ 8 (omitted)

- Non-official table of contents

§ 9

By way of derogation from § 1 in conjunction with Appendix 1, if the If the substance is Na-nifur-styrene or the substance Sarafloxacin is concerned, a veterinary medicinal product intended exclusively for use in the animal species referred to in § 60 (1) of the Medicines Act and before the 1. The European Commission has been on the market in January 2010, and is still under 1. No prescription will be issued in January 2012. Non-official table of contents

Appendix 1 (to § 1 No. 1 and § 5)
Substances and preparations according to § 1 no. 1

The asset contains the following basic principles: Use of the INN nomenclature is an alphabetically ordered list of substances and preparations.
Prescription only, unless otherwise specified in individual cases, also medicinal products which are the respective salts of the following
Under external use for the purposes of this overview, the use of skin, hair or nails is to be understood. Abacavir
Abamectin
Abarelix
Abatacept
Abirateron and its esters
Acamprosat
Acarbose
Acebutolol
Acecarbromal
Aceclidin
Aceclofenac
Acemetacin
Acenocoumarol
acetanilide
Acetazolamide
acetylcholine
-for parenteral use-
acetylcysteine
-except For oral use in acute colds in humans-
N-acetylgalactosamine-4-sulfatase from humans, recombinant, modified (galsulfase)
acetylsalicylic acid
-for parenteral use-
Aciclovir
-except in preparations as cream for use in herpes labialis in pack sizes of up to 2 g and with an active substance content of up to 100 mg per dose of medicinal product-
Acipimox
Acitretin
Aclarubicin
Aclidinium salts
Aconitum: species of the Genus Aconitum, its plant parts and preparations thereof, as well as aconitum alkaloids and their derivatives
except for external use in ointments-
-except in homeopathic preparations for oral use, which are used in accordance with the Manufacturing Regulations 25 and 26 of the Homeopathic Pharmacopoeia are manufactured-
Adaptal
adefovir
Ademetionin
adenosine
Afatinib
Aflibercept
Agalsidase alfa and beta
Agaricinic acid
Aglepriston
-to Use in animals-
Agomelatine
Ajmalin and its esters
N2-L-Alanyl-L-glutamine
-for parenteral use-
Alatrofloxacin
Albendazole
Alclofenac
Alclometason and its esters
Aldesleukin
Aldosterone and its Halbacetal
alendronic acid
Alfacalcidol
Alfadolon and its esters
Alfaxalon
Alfuzosin
Alglucosidase alfa
Alipogen Tiparvovec
Aliskiren
Alitretinoin
Alizapride
Alkuronium salts < br /> N-Alkylatropinium Salts
Allopurinol
Allylestrenol
Almotriptan
-except for the acute treatment of the headache phase in migraine attacks with and without aura in adults between 18 and 65 years of age, after initial diagnosis of a Migraine by a doctor, in solid preparations for oral use in concentrations of 12.5 mg per form divided and in a total amount of 25 mg per package-
Alogliptin
Alprenolol
Alprostadil
Alteplase
Altrenogest
-for use in animals-
Altretamine
Amantadin
Ambenonium salts
Ambrisentan
Ambroxol
-for parenteral use-
Ambutonium bromide
Amcinonide
Ameziniummetilsulfate
Amifampridin
Amifostin
Amikacin
Amilomer
amiloride
4-aminobenzoic acid
-unless a daily dose of up to 1.5 g is given on containers and outer envelopes-
aminocaproic acid
aminoglutethimide
4-amino-2-hydroxybenzoic acid and their derivatives
4-(aminomethyl) benzoic acid
-for oral and parenteral use-
5-amino-4-oxopentanoic acid
Aminopterin
Amiodarone
Amiphenazole
Amisulprid
Amitraz
-for use in pigs-
Amitriptyline
amitriptylinoxide
amlexanox
amlodipine
amodiaquin
amoxicillin
amperozide
-for use in animals-
Amphotericin B
ampicillin
amprenavir
Amrinon
Amsacrin
Amygdalarum amararum aethereum, oleum (bleed)
Amylene hydrate
Isopentyl nitrite
Anagestone
Anagrelide
Anakinra
Anastrozole
Ancrod
Androstanolon and its esters
Androstenon
-for use in animals-
Anetholtrithion
angiotensinamide
Anidulafungin
Anistreplase
antimony compounds
-except antimony (III)-sulphide and antimony (V)-sulphide-
antithrombin-III
aortic valve of porcine, denatured
apalcillin
Apiol
Apixaban
Apomorphine
Apraclonidine
Apramycin
-for use in animals-
Aprepitant
Aprindin
Apronalid
Aprotinin
Ardeparin
-for parenteral use-
Arecolin
Argatroban
Arginine Oxoglurat
Aripiprazole
Arsen and its compounds
species imol and its esters and ethers
Artemether
articain
ascaridol
asenapin
l-Asparaginase
aspidinolfilizin
astemizol
atazanavir
Atenolol
Atipamezol
-for use in animals-
Atomoxetin
Atorvastatin
Atosiban
Atovaquon
Atracurium salts
Atropin
Auranofin
Aurothioglucose
Avanafil
Axitinib
Azacitidine
Azacosterol
Azamethonium salts
Azaperone
Azapropazone
Azatadin
Azathioprine
Azelaic acid
Azelastine
-except for intranasal use for the treatment of seasonal allergic rhinitis in adults and Children from the age of 6. Life-year-
-except for the application on the eye-
Azidamfenicol, its esters and compounds
Azidocillin
Azilsartan and its esters
Azithromycin
Azlocillin
Azosemide
AztreonamBacampicillin
Bacillus Calmette-Guérin
-for immunostimulation-
Bacitracin
-excluding preparations for topical application in humans to the skin or mucous membrane, provided that they are per piece of graduated medicinal product or in the case of other preparations per gram or Milliliters no more than 500 IU (9.1 mg) Bacitracin contains-
Baclofen
Bambuterol
Bamifyllin
Bazedoxifen and its esters
Becaplermin
Beclamid
Beclometason and its esters
-except Beclometasondipropionate for intranasal use in the short-term treatment of seasonal allergic rhinitis in pack sizes up to 5.5 mg of beclometasondipropionate, provided that the containers and outer envelopes indicate that the application has to be Adults and children from the age of 12. -
Befunolol
Belatacept
Belladonnae folium and its preparations
-except for external use-
-except in homeopathic preparations for oral use, which are used in accordance with the Manufacturing regulations 25 and 26 of the homeopathic pharmacopoeia are manufactured-
Bemegrid
Bemetizid
Bemiparin
-for parenteral use-
Benactyzin
Benazepril
Bencyclan
Bendamustin
Bendroflumethiazid
Benfurodil and its esters
Benmoxin
Benperidol
Benserazid
Bentiromid
benzaldehyde cyanohydrin
benzaldehyde thiosemicarbazone and its derivatives
Benzatropin
Benzbromaron
Benzetimid
- For use in animals-
Benzilonium bromide
Benzocain
-except for medicinal products for application to the skin or mucous membrane, except for use in the eye-
Benzoctamine
Benzthiazid
Benzydamine
-except for the Application in the mouth and throat area
a)
as a solution with a benzydamine hydrochloride concentration of a maximum of 1.5 mg/ml or
b)
as a lutschtablette with a maximum of 3 mg of benzydamine hydrochloride per divisive form-

benzylhydrochlorothiazide
benzylpenicillin and its esters
narcotics, insofar as they are preparations according to § 2 para. 1 No. 3 of the Narcotics Act
Betahist
Betain
Betamethasone and its esters
Betanidin
Betaxolol
Betiatid
-as a carrier substance for ((high) 99m Tc) Technetium-
Bevonium salts
Bexarotene
Bezafibrat
Bicalutamide
Bicisat
-as a radiodiagnostic kit with ((high) 99m Tc) technetium-
Bilastin and its esters
Bimatoprost
Biperiden
2,5-bis (aziridin-1-yl) -3,6-b is (2-methoxyethoxy) -1,4-benzoquinone
bismuth and its compounds
-for oral use-
-for intramammary use in cattle-
-except in daily doses up to 1.5 g bismuth and in pack sizes up to 50 g bismuth; this exception does not apply to bismuth (III)-citrate-hydroxide-complex-
Bisoprolol
Bithionoloxid
Bitoscanat
Bitter mandelwater
Bivalirudin
Lead acetate
-except lead vinegar-
Lead (II) iodide
Bleomycin
Blood coagulation factors and coagulation inhibitors, in each case recombinant
blood preparations of human origin
-for use on or in the human or animal body-
Boceprevir
Boldenon and its esters
Bopindolol
Bornaprin
Bortezomib
Bosentan
Bosutinib
Bretylium salts
Brimonidine
Brinzolamide
Brivudine
Bromelain-Proteases-Concentrate
Bromethane
Bromfenac and its Ester
Bromisoval
Bromociclen
Bromocriptine
Bromofenofos and its esters
Bromoform
Bromoprid
Bromperidol
Brotianid
-for use in animals-
Brucin
Buclizin
Budesonid
Budipin
Bufeniod
Buflomedil
Bumadizon
Bumetanid
Bunamidine
-for use in animals-
Bunazosin
Bunitrolol
Bupivacain
Bupranolol
Bupropion
Buserelin
Buspiron
Busulfan
Butalamin
Butamirat
Butenafin
Butizid
Butorphanol and its esters
butylchloralhydrate
butylscopolamine
-for parenteral use -C1 inhibitor of human
Cabazitaxel and its esters
Cabergolin
Cactinomycin
Calabar semen and its preparations
Calcifediol
Calcipotriol
Calcitonin as well as calcitonin-containing organ preparations
Calcitriol
Calcium dobesilate
Cambendazole
-for use in animals-
Canagliflozin and its derivatives
Candesartan and its esters
Canrenoinic acid and its esters
Cantharides and their preparations
-except for external use in plasters, ointments or similar preparations-
Cantharidin
Capecitabine
Capreomycin
Capsaicin and its esters
-for the treatment of peripheral neuropathic pain-
Captodiam
Captopril
Caramiphen
Carazolol
Carbachol
Carbamazepin
N-(2-(carbamoyloxy) propyl) -N, N, N- trimethylammonium hydroxide
Carbenicillin
Carbenoxolon
Carbetocin
Carbidopa
Carbimazole
Carbocistein
Carboplatin
Carbromal
Carbuterol
Carfecillin
Carglumic acid
Carindacillin
Carisoprodol
Carmustin
L-carnitine
-for parenteral use-
Carprofen
Carteolol
Carvedilol
Carzinophillin
Caspofungin
Catalase
Cefacetril
Cefaclor
Cefadroxil
Cefalexin
Cefalonium
-to Application in animals-
Cefaloridin
Cefalotin
Cefamandol and its esters
Cefapirin
Cefapirin-Benzathin (2: 1)
-for use in beef-
Cefazedon
Cefazolin
Cefepim
Cefetamet and its esters
Cefixim
Cefmenoxim
Cefodizim
Cefoperazon
Cefotaxin
Cefotetan
Cefotiam
Cefovecin
-for use in animals-
Cefoxitin
Cefpodoxim and its esters
Cefquinom
Cefradin
Cefsulodin
Ceftarolinfosamil and its esters
Ceftazidim
Ceftibuten
Ceftiofur
Ceftizoxim
Ceftriaxon
Cefuroxim and its esters
Celecoxib
Celiprolol
Certoparin
-for parenteral use-
Ceruletide
Cetrorelix
Chenodeoxycholic Acid
Chenopodii anthelminthici, Oleum
Chinidine
Chinin
-for use in humans-
Chloralformamide
Chloralhydrate
Chloralose
Chlorambucil
Chloramphenicol and its esters and their compounds
Chlorcyclizine
Chlorisondamine
Chlormadinon and its esters
Chlormethaqualon
Chlormethine
Chlormethine-N-oxide
Chlormezanone
Chlornaphazine
chloroform
-except preparations for external use at a concentration of up to 50%-
chloroprocaine
chloroquine
chlorothiazide
chlorotrianises
chlorpropamide
chloropropionate
chlortalidone
chlorotetracycline
chlorzoxazon
Chondroitinpolysulfate
-for parenteral administration-
Choriogonadotropin alfa
Chorionic gonadotropin (human alpha-subunit protein reduced)
Chorionic gonadotropin (human beta-subunit protein reduced)
Chorionic acid
Choriongonadotropin
Chrysoidin
Chymopapain
-for parenteral use-
Ciclacillin
Ciclesonid
Cicletanin
Ciclonium salts
Ciclopirox
-except for external use in adults and school children-
Ciclosporin
Cidofovir
Cilazapril
Cilostazol
Cimetidin
Cimicoxib
-for use in animals-
Cinacalcet
Cinchocain
Cinchophen and its esters
Cinnarizin
Cinoxacin
Ciprofloxacin
Cisapride
Cisatracurium Salts
Cisplatin
Citalopram
Cladribin
Clanobutin
-for use in animals-
Clarithromycin
Clavulanic acid
Clenbuterol
Clevidipine
Clidinium bromide
Clindamycin and its Ester
Clioxanid
Clobetasol-17-propionate
Clobetasonbutyrate
Clocortolon and its esters
Clodronic acid
Clofarabin
Clofazimin
Clofenamide
Clofezon
Clofibric acid and its esters
Clomethiazole
Clomifen
Clomipramine
Clonidin
Clopamide
Clopenthixol and its esters
Clopidogrel
Clopidol
Cloprednol
Cloprostenol
-for use in animals-
Clorexolon
Clorindion
Closantel
-to Use in animals-
Clostebol and its esters
Clostridium botulinum neurotoxin type A (free of complex proteins)
Clostridium botulinum toxin type A and B
Clotrimazole
-except for external use-
-except for For vaginal use in pack sizes of up to 600 mg clotrimazole, distributed to up to 3 individual doses, and for an application period of up to 3 days-
Cloxacillin
Clozapine
Cobicistat
Coffein
-in Preparations containing one or more of the following analgesically active substances
a)
Paracetamol
b)
Pyrazolonderivate
c)
salicylic acid derivatives

(except in single doses up to 0.5 g and a total amount of up to 10 g per pack for the analgesic active ingredients)
-in preparations for Treatment of primary apnoea in premature infants-
Colchici flos, semen et tuber and their preparations
Colchicumalkaloids, also hydrogenated
Colecalciferol
-except in preparations
a)
for use in people, if a daily dose of up to 1 000 is available on containers and outer envelopes I.E. (equivalent to 0.025 mg) Colecalciferol is indicated,
b)
for use in animals, if a daily dose of up to 10 000 IU is available on containers and outer envelopes. (equivalent to 0.25 mg) Colecalciferol is indicated-

Colesevelam
Colestilan
Colestipol
Colestyramine
Colistimethat-sodium and other colistimethat salts
Colistin
Colocynthidis fructus and their preparations
Conii herba and its preparations
except for external use in plasters, ointments and similar preparations and as additive to softening herbs-
Coniin
Convallaria-Glycoside
Corifollitropin alfa
Corticorelin from the human
Corticotropin, also functional parts
Cortison and its esters
Coumafos
-except for external use-
Crizotinib
Cropropamid
-except preparations
a)
for use in humans, provided that they are not more than 25 mg or less per piece of the drug. Injection solution not more than 75 mg per millilitre,
b)
for use in animals, provided that they are not more than 75 in oral or nasal preparations. mg per millilitre-
Crotonis oleum
Crotonis semen and its preparations
Crufomat
Curare and its preparations
Cyacetacid
Hydrogen cyanide
-except as a stabilizer in preparations for oral and parenteral use in daily doses up to 100 my g, based on the cyanide content-
cyclodrin
Cyclofenil
Cyclopenthiazid
Cyclopentolate
Cyclophosphamide
Cycloserine
Cyclothiazid
Cyproheptadin
Cyproteron and its esters
Cytarabin
Cytisin

Dabigatran and its esters
Dabrafenib
Dacarbazin
Dactinomycin
Dalfopristin
Dalteparin
-for parenteral use-
Danaparoid
Danazol
Danofloxacin
- for use in pigs, beef and chicken-
Dapagliflozin and its esters
Dapiprazole
Dapoxetin
Dapson
Daptomycin
Darbepoetin alfa
Darifenacin
Darunavir
Dasatinib
Datura species and their preparations
excluding in homeopathic preparations for oral use from above-ground parts of Datura stramonium for flowering time, which are manufactured in accordance with the manufacturing rules 25 and 26 of the homeopathic pharmacopoeia-
Daunorubicin
Deanol
-except preparations, provided that a daily dose of up to 50 mg, calculated as Deanol, on containers and outer wraps is indicated-
Decitabin and its esters
Deferasirox
Deferipron
Deferoxamine
Defibrotid
Deflazacort
Defosfamid
Degarelix
Delapril
Delmadinon and its esters
Dembrexin
-for parenteral use in animals-
Demeccarium bromide
Demeclocyclin
Demecolcin
Demegeston
Demelverin
Denaverin
Depreotid
Desfluran
Desipramine
Desirudin
Desloratadin
Deslorelin
-for use in animals-
Desmeninol
Desmopressin
Desogestrel
Desonid
Desoximetason
Desoxycorton, its esters and glucoside compounds
Destomycin A
-for use in animals-
Detajmium bitartrate
Detomidine
-for use in cattle and horses-
dexamethasone and its esters
-except Dexamethasone dihydrogen phosphate for single parenteral use in aqueous solution in ampoules/pre-filled syringes containing 40 mg of active substance and up to a maximum of 3 pack units (equivalent to 120 mg of active substance) for emergency treatment of severe Anaphylactic reaction in humans after neural therapy up to the arrival of the rescue service-
Dexibuprofen
Dexketoprofen
Dexmedetomidine
-for use in dogs and cats-
Dexrazoxan
Dextrane
-to intravenous use-
dextrofemin
dextrothyroxine
diacetylnalorphine
diacetylsplenopentin
4,4 '-diamino-2,3', 5 ', 6-tetraiododiphenyl sulfone
Dibekacin

Dibenzepine
N, N-dibenzyl-N-(2-chloroethyl)-amine
Dibotermin alfa
1,2-Dibromethane
1,1-dichloroethane
1,2-dichloroethane
dichlorvos
Diclazuril
-for use in sheep-
Diclofenac
-except for cutaneous use in concentrations up to 5% with the exception of the Use in thrombophlebitis superficialis and actinic keratosis-
-except in oral administration to treat mild to moderate pain and fever in a dosage of up to 25 mg per divided form and a daily dose of 25 up to a maximum of 75 mg for a maximum application period of three (antipyresis) or four (analgesia) days-
Diclofenamide
Dicloxacillin
Dicoumarol
Dicyclanil
-for use in sheep-
didanosine
dienestrol
dienogest
diethyl carbamazin
1-(2-(2-(diethylmethylazaniumyl) ethoxy) ethyl) -1-methylpyrrolidinium diiodide
diethyl-p-nitrophenyl phosphate
diethylstilbestrol
Diflorasone-17, 21-diacetate
Difloxacin
-for use in chicken, Dog, Pute and Rind-
Diflucortolon and its esters
Diflunisal
Digitalis folium, glycoside-containing and its preparations
Digitalis active ingredients, genuine and partially degraded glycosides
-excluding digitoxin for external use, if a daily dose of up to 0.0015 g is indicated on containers and outer sheaths-
N-(2 ,3-dihydro-1,4-benzodioxin-2-ylmethyl) -3-methoxypropan-1-amine
Dihydralazine
dihydrocuprein and its derivatives
dihydroergocornin
dihydroergocristin
dihydroergocryptin
dihydroergotamine
1,1-Dioxo-3-(2-phenylethyl) -6-trifluoromethyl-3,4-dihydro-2H-1 lambda (high) 6,2,4-benzothiadiazine-7-sulfonamide
dihydrostreptomycin
dihydrotachysterol
Dilazep
Diltiazem
Dimepranol (4-acetamidobenzoate)
dimenhydrinate
-for parenteral use-
2,3-Dimercapto-1-propanesulphonic acid
Dimetacrin
Dimetamfetamine
Dimethisterone
Dimethocain
(3-Dimethylamino-2-hydroxypropyl)-(4-propylaminobenzoate)
4-Dimethylaminophenol
O-(4-Dimethylsulfamoylphenyl) -O ', O ''-dimethylthiophosphate
0.0' -dimethyl-0 ''-(4-sulfamoylphenyl) thiophosphate
dimethyl fumarate
-for oral administration -
dimethyl sulphoxide
-except for cutaneous use in humans at a concentration of up to 15%-
dimethyl tubocurarin
Dimetinin
-for parenteral use-
Dimetridazole
-for use in animals-
Dinoprost
Dinoproston
Diphenhydramine
-for parenteral use-
Di (L-(+)-ornithine)-(2-oxoglutarate)-hydrate-diphosphonic acid
-as a carrier substance for ((high) 99m Tc) technetium-
3,3-diphosphono-1,2-propanedicarboxylic acid- as a carrier for ((high) 99m Tc) technetium-
Dipiproverin
Dipivefrin
Dipyridamol
Dirlotapid
-for use in animals-
Disopyramide
Distigmine
Disulfiram
Dithranol
Dobutamine
Docetaxel
Dofetilid
Dolasetron
Domperidon
Donepezil
dopamine
dopexamine
doramectin
-for use in beef, sheep and pigs-
Doripenem
Dornase alfa
Dorzolamide
Dosulepin
Doxapram
Doxazosin
Doxepin
Doxorubicin
Doxycyclin
Droloxifen
Dronedaron
Dropempin
Droperidol
Drospirenon
Drostanolon and its esters
Duloxetine
Dutasterid
Dydrogesterone

Ebastin
Econazole
- except for external use-
Ecothiopat
Edoxudin
Efavirenz
Eflornithine
Iron (III)-hexacyanoferrate (II)
Iron compounds
-for parental use, except for the prophylaxis of iron deficiency anaemia Suction piglets, provided that this is specified as the sole application on containers and outer wraps-
Eletriptan
Eltrombopag
Elvitegravir and its esters
Emedastin
Emepronium salts
Emetin
Emtricitabin
Emylcamat
Enalapril
Enalaprilat
Endomid
Enfluran
Enfuvirtid
Enoxacin
Enoxaparin
-for parenteral use-
Enoximon
Enrofloxacin
-for use in animals-
Entacapon
Entecavir
Enzalutamide
enzymes, proteolytic, animal or plant origin
-for parenteral use-
Ephedra species and preparations of Ephedra species
-for oral use, with the exception of homeopathic preparations from Ephedra in higher dilutions other than D1 and other than in homeopathic preparations manufactured in accordance with the manufacturing rules 25 and 26 of the homeopathic medicinal product-
Ephedrine
-for oral use
a)
in preparations to which only this substance or substance, together with caffeine, is an active ingredient ,
b)
in other preparations, provided that a single dose of more than 10 mg or in the case of prolonged-release preparations, on containers and outer envelopes, is a single dose; Daily dose of more than 40 mg, calculated as ephedrinbase, given or these preparations contain caffeine-
Epicillin
Epimestrol
Epinastin
Epinephrin
-excluding autoinjectors in pack sizes of one unit Single parenteral administration for emergency treatment of severe anaphylactic reactions in humans following neural therapy until the rescue service is received-
Epirubicin
Eplerenon
epoetin alfa, beta, delta, theta and zeta
Epoetin alfa, beta, delta, theta and zeta
Epoprostenol and its derivatives
Eprazinon
Eprinomectin
Eprosartan
Eptifibatid
Eptotermin alfa
Erdostein
Ergocalciferol,
-except preparations
a)
for use in people, if a daily dose of up to 1 000 is available on containers and outer envelopes I.E. Ergocalciferol is indicated,
b)
for use in animals, provided that a daily dose of up to 10 000 IU of ergocalciferol is given on containers and outer sheaths. is-

Eribulin and its derivatives
Eritrityl tetranitrate and other nitrate derivatives of erythritol
Erlotinib
Nutrition solutions using carbohydrates, calorie-containing sugar substitutes, fat emulsions, or Glucogenic or ketogenic amino acids
-for parenteral use-
Ertapenem
Erythromycin and its esters
Escherichia coli, live
-for oral use in animals-
Esketamine
Eslicarbazepine and its esters
Esmolol
Esomeprazole
-except for the treatment of heartburn and acid retreat in a single dose of 20 mg and at a maximum daily dose of 20 mg for a maximum period of 14 days and in a maximum pack size from 280 mg of active ingredient-
estradiol and its esters
Estramustine-17-dihydrogen phosphate
Estriol
Estrogene, conjugated
Etacrynic acid
Etafenon
Etamsylat
in animals-
Etanercept
Etaqualon
Ethadion
Ethambuto l
Ethiazid
ethinylestradiol and its esters
ethionamide
Ethisteron
Ethosuximide
6-ethoxy-2-benzothiazolesulfonamide
ethyl benzhydramine
Coumessiacetic acid and its esters
Ethylestrenol and its esters
2-ethyl hex-2-enal
-for use in animals-
Ethyl hydrogen fumarate
-for oral use-
Ethyl nitrate
Etidocaine
etidronic acid
etiproston
-for use in cattle-
Etiroxat
Etodolac
Etodroxizin
Etofenamat
except for outer use-
etofibrat
etofyllinclofibrat
etoloxamine
etomidat
etonogestrel
etoposid
etoricoxib
etozolin
etravirin
Etretinat
etynodiol and etoricoxib
etoposid
etoposid
etoricoxib
etoposid its esters
Everolimus
Exametazim
Exemestan
Exenatide
Ezetimib
Famciclovir
Famotidin
-except in solid preparations for oral use in a concentration of up to 10 mg per divided form and in Pack sizes up to 140 mg, provided that the application for adults and children is 16. Year of life is limited to applications "for short-term use in heartburn and/or acid impact" and to a maximum therapy duration of 14 days-
Fampridin
Febantel
-for use in animals-
Febuprol
Febuxostat
Felbamat
Felodipine
Fenbendazole
-for use in animals-
Fenbufen
Fenbutrazat
Fenclofos
Fendilin
Fenfluramin
Fenofibrat
Fenoprofen
Fenoterol
-except for Emergency tokolysis in preparations of 25 my g for dissolution in 4 ml solution for infusion for slow (over 2-3 minutes) bolus injection in a pack size of up to 5 ampoules for delivery to midwives and debinding plasters for the practical use-
Fenprostals
-for use in animals-
Fenthion
Fentonium bromide
Fenyramidol
Fertirelin
-for use in animals-
Ferucarbotran
-to depict herd-shaped liver damage in the Magnetic resonance tomography (MRI)-
Ferumoxytol
Fesoterodin
Fexofenadin
Fibrinolysin (human)
Fidaxomicin and its derivatives and analogues
Filgrastrim
Filicis rhizoma and its preparations
Finasterid
Fingolimod and its derivatives
Firocoxib
-for use in animals-
Flecainid
Fleroxacin
Flomoxef
Flopropion
Florfenicol
Fluanison
Flubendazole
-for use in animals-
Flucloxacillin
Fluconazole
Flucytosine
Fludarabin-5 '-dihydrogen phosphate
Fludeoxyglucose ((high) 18F)
Fludrocortisone and its esters
Fludroxycortid
Flufenamic acid
-except for cutaneously application-
Flumazenil
Flumetason and its esters
Flumethrin
-for use in cattle-
Flunarizin
Flunisolate
Flunixin
-for parenteral use in animals-
-for use in dogs-
Fluocinolonacetonide
Fluocinonide
Fluocortin-butyl
Fluocortolon and its esters
fluorescein
-for parenteral use-
fluorides, soluble,
-unless a daily dose of a fluorine content is indicated on containers and outer envelopes 2 mg corresponds to-
-except in preparations as a gel for local use on the teeth in pack sizes of up to 25 g, provided that it is indicated on containers and outer envelopes, that the application to adults and children from the completed 6. -
fluorometholone and its esters
fluorouracil
fluorophenylalanine
Fluostigmine
Fluoxetine
Fluoxymesterone and its esters
Flupentixol
Flupirtine
Flupredniden and its esters
Fluprostenol
-for use in animals-
flurbiprofen
-except for oral and pharyngeal use for short-term symptomatic treatment painful inflammation of the oral and pharynx mucosa at a maximum daily dose of 50 mg-
flutamide

fluticasone and its esters
fluvastatin
fluvoxamine
folinic acid
-for parenteral use in the Treatment of cancer or rheumatic diseases-
Follitropin
Follitropin alfa and beta
Fomepizol
Fomintop
Fomiviruses
Fomocain
-except for medicines to apply to the skin or mucosa, except for Application on the eye-
Fondaparinux
Formestan
Formocortal
Formoterol
Fosamprenavir
Fosaprepitant
Foscarnet
-for cutaneous and parenteral use-
Fosfestrol
Fosfomycin
Fosinopril
Framycetin
Frovatriptan
Fulvestrant
Furaltadon
Furazolidone
Furosemide
Fusidic acid and its ester gabapentin
Galantamine
Gallamine
Gallopamil
Gamithromycin
-for use in animals-
Ganciclovir
Ganirelix
Gatifloxacin
Gaxiless
Gefitinib
Gelsemii rhizoma and its preparations
other than in homeopathic preparations for oral use, which are in accordance with the manufacturing rules 25 and 26 of the homeopathic Medicines produced-
Gemcitabine
Gemeprost
Gemfibrozil
Gentamycin
gene transfer medicines
Pinned
Gestoons
Gestonoron
tissue transplants, human allogeneic and tissue engineered products
Gitoformat
Glafenin
Glatiramer
Glibenclamid
Glibornurid
Gliclazid
Glimepirid
Glipizid
Gliquidon
Glisoxepid
Glucagon
Glucametacin
Glucosamin
-except for oral application-
glycerol trinitrate
glycopyrronium bromide
glymidine
gold keratin complex
gonadorelin
gonadorelin (6-D-Phe) acetate
-for use in animals-
gonadotrophin (human and horse desertion)
Goserelin
Granisetron
Grepafloxacin
Griseofulvin
Green leaf dry extract (purified dry extract from Camellia sinensis (L.) O. Kuntze (45-56: 1), corresponding to 55-72% (-)-Epigallocatechin-3-(3,4,5-trihydroxybenzoate))
Guanabenz
Guanaclin
Guanethidine
Guanfacin
guanidine, also attached to protein
Guanoxan
Gutti and its preparation Halcinonide
Halofantrin
Halofuginone
-for use in animals-
Halometason
Haloperidol and its esters
Halothan
Haloxon
((high) 13C) urea
((high) 14C) urea
Hemoglobinglutamer
-for use in animals-
Heparine
-for parenteral use-
Hetacillin
Hexachlorethane
-for use in animals -
Hexachlorophen
-except for external use in a concentration of up to 1% by weight-
Hexacyclonic acid
hexamethonium salts
Hexcarbacholine bromide
Hexobendin
Hexoprenaline
Hexyl (5-amino-4-oxopentanoate)
Histamine
-except
a)
oral use preparations, if they do not contain more than 0.4 mg of histamine salt per gram or millilitre, and should be taken in drops,
b)
preparations for external use -

Histrelin
Homatropin
Human plasma proteins with factor VIII inhibitor bypass activity
Human plasma proteins with factor VIII corrective activity
hyaluronic acid
-for intraarticular application-
-to Intravenous use in horses-
Hydantoin and its derivatives
-except for allantoin-
Hydralazine
Hydrastinin
Hydrastiswurzelstock and its preparations
-except preparations that are no longer per millilitre as 1.21 mg hydrated alkaloids, calculated as hydrastin, for application to the oral mucosa-
-except in homeopathic preparations for oral administration, which are based on the manufacturing rules 25 and 26 of the homeopathic -
Hydrochlorothiazide
Hydrocortisone and its esters
-except in outer use preparations
a)
in a concentration of up to 0.25% hydrocortisone or hydrocortisone acetate, calculated as base and in pack sizes up to 50 g, as well as
b)
in a concentration of over 0.25 up to 0.5% hydrocortisone or hydrocortisone acetate, calculated as base and in pack sizes up to 30 g for a short term (maximum two weeks) (persistent) external use for the treatment of moderate inflammatory, allergic or itchy skin diseases,
and provided that there is a restriction of use on both adults and children on containers and outer envelopes. from the completed 6. -
Hydroflumethiazid
Hydroxocobalamin
-for the treatment of a known or suspected cyanide poisoning-
Hydroxycarbamide
8-hydroxyquinaldine, halogenated and its esters
-except for use in the oral cavity, if a daily dose of up to 20 mg is indicated on containers and outer sheaths, and for external use-
8-hydroxyquinolines, halogenated and their esters
-except for external use-
hydroxychloroquine
hydroxydione and its esters
17β-hydroxy-17-methylestr-4-en-3-one (methylestratiolone)
hydroxyprogesterone
hydroxystilbamidine
hydroxyzine
Hygromycin A
Hyoscyami folium et herba and their preparations
-Excluded for external use-
Hyoscyamin
Hypophye rear lobe and its preparations
Hypromellose
-for use on the opened eye -Ibafloxacin
Ibandronic acid
Ibuprofen
-except for external use in a concentration of up to 5% by weight-
except for oral use without the addition of any other active substance in a concentration of up to 400 mg per divided form and in a daily dose up to 1 200 mg Mild to moderate pain and fever-
-except in solid preparations for rectal use as monopreparate in single doses up to 10 mg/kg body weight (up to a maximum single dose of 600 mg per divided form), and in a daily dose of up to 30 mg/kg body weight (up to a maximum daily dose of 1 800 mg) for mild to moderate pain and fever-
-except for oral use in liquid preparations without the addition of further medicinal products active ingredients for adults and children from 6 months of age in individual doses up to 10 mg/kg body weight (up to a maximum daily dose of 1 200 mg) for mild to moderate pain and fever-
-except for oral use in Doses up to a maximum of 400 mg per divided form and at a maximum daily dose of 1 200 mg, for rectal use in solid preparations as monopreparate in single doses up to 10 mg/kg body weight up to the maximum single dose of 600 mg per dose Divided form and up to the maximum daily dose of 30 mg/kg body weight or 1 800 mg, for the treatment of acute headache in migraine with or without aura-
except for oral administration (in a maximum single dose of 400 mg and in the case of a single dose of 400 mg and in the case of a single dose of Aura). a maximum daily dose of 1 200 mg) in combination with pseudoephedrine hydrochloride (at a maximum single dose of 60 mg and at a maximum daily dose of 180 mg) with a total amount of active substance of up to 720 mg of pseudoephedrine and 4 800 mg of active substance. Ibuprofen per pack, for the treatment of acute rhinosinusitis associated with other colds (such as: B. Fever and pain)-
Icatibant
Idarubicin
Idoxuridine
Idursulfase
Ifos famid
Iloprost
Imatinib
Imepitoin
-for use in animals-
Imiclopazin
imidapril
Imiglucerase
Imipenem
Imipramin
Imiquimod
Imolamine
vaccines
-for use on or in the human body; the regulations of the animal vaccine regulation for prescription remain unaffected-
Indacaterol
Indapamide
Indinavir
Indocyaningrün
Indometacin
-except for cutaneous use in 1% solution-
Indoramin
Indoxacarb
-for use in animals-
Ingenol mebutate and its esters
myo-inositolhexanitrate
Inproquon
Insulin, Furthermore, products manufactured from the pancreas and intended for injections in diabetes mellitus
Insulin aspart
Insulin defalan (from beef)
Insulin degludec
Insulin detemir
Insulin glargine
Insulin glulisin
Insulin lispro
insulin (from the pig) -zinc injection suspension, crystalline
-for use in animals-
Interferons
Intrauterinpessare
-for pregnancy prevention-
Iodethan
iodine solutions and Iodine preparations for the preparation of iodine solutions
-except for external use-
-except in preparations for internal use in animals, if the ready-to-use solution does not exceed 5% iodine-
Iodine

-except for external use-
Iosarcol
Iotrolan
-for intravascular use-
Ipecacuanhae radix and its preparations
Ipratropium bromide and its esters
Iprazochrom
Iproclozid
Ipronidazole
-for use in animals-
Irbesartan
Irinotecan
Isoaminil
Isocarboxazid
Isoconazole
-except for external use-
Isoetarin
Isoflurane
Isonicotinaldehyde and its derivatives
Isonicotinic Acid Hydrazide and its derivatives
Isoprenalin
-excluding preparations for external use in a concentration of up to 0.5% by weight-
isopropamidiodid
Isosorbide dinitrate
Isosorbide mononitrate
Isotretinoin
Isradipin
Itraconazole
Ivabradin
Ivacaftor
Ivermectin
-for use in TierenJalapae resina et tuber and their preparations
St John ' s wort
-for the treatment of moderate depression-
Josamycin and its esterpotassium
-for parenteral use in concentrations of more than 6 mmol/l-
Potassium bromide
-for systemic use-
Potassium dichromate
Kanamycin
Kava-Kava-rootstock and its preparations
-except in homeopathic preparations for oral use produced according to article 26 of the homeopathic pharmacopoeia-
Kavain
Kebuzon
ketamine
Ketanserin
-for use in animals -
Ketoconazole
-except for external use-
Ketoprofen
Ketorolac
-for use in the eye-
Ketotifen
-except for use in the eye at a concentration of up to 0.025%-
kitasamycin
Collagen
-for injection-
contrast medium
-for use in X-ray, magnetic resonance or ultrasound diagnostics-
Creosote
-except for preparations for external use in a concentration of up to 50 Weight% -Labetalol
Lacidipine
Lacosamide
Lactobacillus salivarius
Lactucavirosa preparations
Lamivudine
Lamotrigine
Lanreotid
Lansoprazol
Lapatinib
Laronidase
Lasofoxifen and its esters
Latamoxef
Latanoprost
Lecirelin
-for use in animals-
Leflunomid
Lenalidomide
Lenograstim
Lepirudin
Lercanidipin
Lespedeza capitata and its preparations
Letrozole
Leuprorelin
Levallorphan
Levamisol
Levetiracetam
Levobunolol
Levobupivacain
Levocetirizine
Levodopa
Levodropropizin
Levofloxacin
Levofolinic acid
Levonorgestrel
-except for oral use without the addition of other active substances in a concentration of up to 1.5 mg of active substance per dose of medicinal product and in packs with a maximum active substance content of 1.5 mg for emergency contraception-
Levosimendan
Lidocain
-excluding medicinal products for parenteral use without the addition of other active substances in a concentration of up to 2% for intracutaneous use in healthy skin within the framework of neural therapy,
Medicinal products for subcutaneous and intramuscular infiltration anesthesia for the performance of dyed incisions and for the sewing of dam sections and dam tears at birth in a concentration of up to 1%, a single dose of up to 10 ml, and an amount of up to 10 ml per ampoule for the delivery of midwives and debindment plasters in the course of their professional exercise-,
-excluding medicinal products for application to the skin or mucous membrane, other than
a)
for the eye and outer auditory canal application,
b)
to alleviate neuropathic pain after a herpes zoster infection (post-zoster neuralgia)-

Lidoflazine
Linaclotid
Linagliptin
Lincomycin
Lindan
Linezolid
Lipegfilgrastim
Liraglutid
Lisinopril
Lisurid
Lithium
-for the treatment of mental illness and psychosis-
Lixisenatid
Lobeliae herba and its preparations
-except for the Smoking and smoking-
Lobelin
Lofepramin
Lomefloxacin
Lomitapid
Lomustin
Lonazolac
Loperamid
-except in solid oral preparations for acute diarrhoea in daily doses up to 12 mg and in Pack sizes of up to 24 mg, provided that the containers and outer envelopes indicate that the application is applicable to adults and children from the age of 12. Lifetime limited-
Loperamidoxide
Loracarbef
Lorcainid
Lornoxicam
Losartan
Loteprednol
Lovastatin
Loxapin
Lufenuron
-for parenteral use in dogs and cats-
Lumefantrin
Lumiracoxib
Luprostiol
-for use in animals-
Lutropin
Lutropin alfa
Lynestrenol
(RS) -3-methyl-2-oxopentanoic acid
3-methyl-2-oxobutanoic acid
4-methyl-2-oxopentanoic acid

MACI (matrix-induced autologous chondrocyte implantation)
Macrogol
-for the treatment of the coprovase in children and adults-
Macrogollaurylether (Polidocanol)
-for sclerotherapy of varices and brooms-
Mafenid and its compounds
Magnesium bis (hydrogen aspartate) dihydrate
-for intracoronary use-
Mandragora officinarum L. and Mandragora autumnalis Bertol, roots of and their preparations
-except for external use-
-excluding Homeopathic preparations for oral administration which are manufactured in accordance with Regulations 25 and 26 of the Homeopathic Pharmacopoeia
Mangafodipir
Manidipine
Mannitolhexanitrat
Mannomustin
Maprotilin
Maraviroc
Marbofloxacin
Maropitant
-for use in animals-
Masitinib
-for use in animals-
Mavacoxib
-for use in animals-
Mazipredon
Mebendazole
Mebeverin
Mebhydrolin
Mecamylamine
Mecasermin
Meclocyclin
Meclofenamic acid
-for use in animals-
-except for use in horses-
Meclozin
Medetomidine
Medrogeston
Medroxyprogesterone and its esters
Medryson and its esters
Mefenamic Acid
Mefloquin
Mefrusid
Megestrol
Melagatran
Melatonin
Melitracen
Meloxicam
Melperon
Melphalan
Memantin
Mepacrin
Mephenesin
Mephenappointment
Mepindolol
Mepivacain
Meproscillarin
Meptazinol
Mequinol
mercaptamine
mercaptopurine
Meropenem
Mertiatide-as a carrier for (99mTc) Technetium-
Mesalazine
Mesna and other salts of 2-sulphanylethanesulfonic acid
Mesterolon and its esters
Mestranol
Mesuximid
Metaclazepam
Metacyclin
Metamfepramon
Metamizol
Metandienon and its esters
Metaraminol
Metaxalon
Metenolon and its esters
Metergolin
Metformin
Methacholin
Methallenestril
Methandriol and its esters
Methanthelinium bromide
Methazolamide
Methocarbamol
Methotrexate
Methoxamine
Methoxsalen
methoxyfluran
Methyclothiazid
Methyl (5-amino-4-oxopentanoate)-hydrochloride
methyldopa
DL-methyldopa
Methylergometrin
-except for use in post-birth haemorrhages in a concentration of up to 0.3 mg/ml and a single dose up to 1 ml for delivery to Midwives and binder for the practical use-
Methylnaltrexonium salts
Methylpentynol and its esters
2-methyl-1-phenylbut-3-in-1,2-diol
Methylprednisolone and its esters
N-Methylscopolaminium salts < br /> Methylsulfonal
methyltestosterone and its esters
methylthioninium salts
-for parenteral use in humans-
Methysergid and its esters
Meticillin
Metildigoxin
Metipranolol
Metoclopramide
Metolazon
Metomidat
Metoprolol
Metrifonat
Metronidazole and its esters
Metyrapon
Metyridine
Mexiletin
Mezlocillin
Mianserin
Micafungin
Miconazole
-except for external use and to Use in the oral cavity-
except for vaginal use in pack sizes of up to 1 043 mg miconazole and for an application period of up to 3 days-
microbial collagenase
Midodrin
Mifamurtid and its esters
Mifepriston
Miglitol
Miglustat
Milrinon
Miltefosin
Minocycin
Minoxidil
-except for topical application in androgenetic alopecia, in a concentration of up to 5%-
Mirabegron and its derivatives
Mirtazapin
Misoprostol
Mitomycin
Mitotan
Mitoxantron
Mitratapid
Mivacurium salts
Mizolastin
Moclobemide
Modafinil
Moexipril
Mofebutazone
Molgramostim
Molsidomin
Mometason and its esters
Monepantel
-to be used in animals-
Monobenzon
Montelukast
Moperon
Morantel
-for use in animals-
Morazon
Moroxydin
Moxestrol
Moxidectin
Moxifloxacin
Moxonidine
Mupirocin
Mycophenolic acid
Myrtecaine
-except for skin or mucous membranes, except for the application to the eye -Nabumeton
Nadroparin
-for parenteral use-
Nifurstyrenoic acid -for use in animals-
Nadifloxacin
Nadolol
Nafarelin
Nafcillin
-for use in animals-
Naftalofos
Naftidrofuryl
Nalbuphin
Nalidixic acid and its esters
Nalmefen and its esters
Nalorphin
Naloxone
Naltrexone
Naproxen
-except in solid oral preparations without the addition of other active ingredients in a concentration up to 250 mg per divisional form and in a daily dose Up to 750 mg and in a pack size up to 7 500 mg for use in adults and children aged 12 years and over in mild to moderate pain and fever-
Naratriptan
-except for the treatment of migraine headache Adults aged between 18 and 65 years, after initial diagnosis of migraine by a doctor, in solid oral preparations in concentrations up to 2.5 mg per form divided and in a total quantity of 5 mg per pack-
Natamycin
-except for external use-
Nateglinide
Sodium aurothiomalate
Sodium gold chloride
Sodium nitrite
Nebivolol
Nedocromil
-except for seasonal allergic rhinitis-
-except for Eye-to-eye application-
Nefazodon
Nefopam
Nelarabin
Nelfinavir
Neodymium 3-sulfoisonicotinate
Neomycin
Neostigmine salts
Nepafenac
Netilmicin
Nevirapine
Nicarbazin
-for use in animals-
Nicardipin
Nicergolin
Niclofolan
Nicotin
-except for oral (including oral inhalation) use without the addition of other active ingredients in a quantity of
a)
up to 150 mg nicotine per dosage form, where the single dose is 1 mg nicotine, and in a single dose Daily dose up to 64 mg or
b)
up to 15 mg nicotine per dose of medicinal product and in a daily dose up to 64 mg-

-except for transdermal Use as plaster without the addition of other active ingredients in a concentration up to 52.5 mg nicotine per dosage of medicinal product. even at higher concentrations, provided that the active substance release of Nicotin on average 35 mg per 24 hours-
-except for the combination of transdermal use with oral (including oral inhalation) application up to a maximum daily dose of 64 mg-
Nifedipine
Nifenalol
Niflumic acid
Nifuratel
Nifurpirinol
Nifurprazine
Nilotinib
Nilutamide
Nilvadipin
Nimesulide
-for use in animals-
Nimodipine
Nimorazole
Nimustin
Niridazole
Nisoldipine
Nitisinon
Nitrendipine
Nitrofural
Nitrofurantoin
Nitrofurathiazid
-for use in animals-
Nitroprussidnatrium
-for intravenous use-
Nitroscanate
-for use in animals-
Nitroxinil
Nitroxolin
Nizatidin
Nomegestrol and its esters
Nomifensin
Norelgestromin
Norepinephrin
-except for external use-
Norethisteron
Noretynodrel
Norfloxacin
Norgestimat
Norgestrel
Norgestosterone
Nortestosterone and its esters
Nortriptylin
Noscapin
Novobiocin
Noxiptilin

Obidoxim
Oclacitinib
-for use in animals-
Octreotide
Oil from deep-sea fish (with )
-for parenteral nutrition-
Ofloxacin
Olanzapine
Oleander-glycoside
Oleandomycin
Olmesartan and its esters
Olodaterol
Olopatadin
Olsalazine
Omega-3-acid ethyl ester
-for adjuvant treatment for secondary prophylaxis after myocardial infarction, in addition to standard treatment (e.g. Statins, platelet aggregation inhibitors, beta-blockers, ACE inhibitors)-
Omeprazole
-except for the treatment of heartburn and acid uptake in a single dose of 20 mg and in a maximum daily dose of 20 mg for a maximum of 20 mg Application time of 14 days and in a maximum pack size of 280 mg of active substance-
Ondansetron
Opipramol
Opium alkaloids
-as far as the prescription and delivery are not carried out by the annexes of the narcotics law in the respective -
Orazamid
Orbifloxacin
Orciprenalin
Orphenadrin
Orgotein
Orlistat
-excluding medicinal products authorised by the European Commission for use in oral and non-prescription medicines Use with a maximum dose of 60 mg per divided form as well as medicinal products for oral administration with a maximum dose of 60 mg per divided form and a maximum daily dose of 180 mg-
ornidazole
Osateron and its esters
Oseltamivir
osmium acid
Osteogenic protein 1
Oxabolon and its esters
Oxaceprol
Oxacillin
Oxaliplatin
Oxaprocin
Oxatomid
Oxcarbazepine
Oxetacain
Oxfendazole
-for use in animals-
oxiconazole
-for vaginal application-
oxiconazole acid
-as a carrier for ((high) 99m Tc) technetium-
oxitriptan
oxitropium bromide
Oxolin
Oxolinic acid
2-oxo-3-phenylpropanoic acid
Oxprenolol
Oxybuprocain
Oxybutynin
Oxyclozanid
Oxymesterone and its esters
Oxymetholone
Oxypertin
Oxyphenbutazone
Oxyphencyclimin
Oxyphenisatin and its esters
Oxytetracyclin and its compounds
Oxytocin
- except for use in post-birth haemorrhages in a concentration of up to 10 IU/ ml and a single dose of up to 1 ml for delivery to midwives and debinding plasters for practical use of -4-phenylbutanoic acid
Paclitaxel
Palifermin
Palonosetron
Pamidronic acid
Pancuronium bromide
Pantoprazole
-excluding medicinal products in pack sizes of no more than 14 divided units in a single dose of 20 mg and at a maximum daily dose of 20 mg for a single dose of 20 mg Short-term treatment, without medical advice, for a maximum of 4 weeks and for daily use for a maximum of 2 weeks limited treatment of reflux symptoms (e.g. (b) Sodburning and Acidic Erasure) in adults-
Papaverin
Paracetamol
-except for medicinal products for human use
a)
oral use for symptomatic treatment of mild to moderately severe pain and/or fever in a total amount of active ingredient of up to 10 g per pack and
b)
rectal application-

Paliperidon
Paraflutizid
Paraldehyde
Paramethadion
Paramethasone and its esters
Paraoxon
Parathyroidhormon from People
Parbendazole
Parecoxib
Pargylin
Paricalcitol
Parnaparin
-for parenteral use-
Paromomycin
Paroxetine
Pasireotid
Pazopanib
Pefloxacin
Peforelin
-for use in animals -
Pegaptanib
Pegaspargases
PEG-Epoetin beta
Pegfilgrastim
Peginterferon alfa-2a
Peginterferon alfa-2b
Pegloticase
Pegvisomant
Pemetrexed
Penbutolol
Penciclovir
-except for external application for herpes labialis in pack sizes of up to 2 g and an active substance content of up to 20 mg of each treated medicinal product-
Penfluridol
Penflutizid
Pengitoxin
Penicillamin
Penoctonium bromide
-except in solutions, ointments and Powder for external use in a concentration of up to 0.1% by weight-
Pentaerithrityltetranitrate
Pentagastrin
Pentamethonium salts
Pentamidine
Pentetreotide
Pentolonium salts
Pentorex
Pentosan polysulfate
-for oral and parenteral use-
Pentostatin
Pentoxifylline
Perampanel
Perchloric acid
Pergolide
Perhexilin
Perindopril
Permethrin
-for the treatment of human scabies-
-for use in animals, except
a)
as ear clip
b)
for use on the horse

Peruvosid
Phenacemid
Phenamacid
Phenelzine
Pheneticillin
Phenglutarimide
Phenindion
Pheniprazin
Phenothiazine
Phenothiazine, nitrogen substituted
phenoxybenzamine
Phenoxymethylpenicillin
Phenprobamat
Phenprocoumon
Phensuximide
Phentolamine
phenylbutazone
Phenylephrin
-for use in the eye, except in liquid preparations up to 2.5%-
((phenyl) (piperidin-2-yl) methyl) acetate
phenylpropanolamine
-for the treatment of nutritional overweight-
-for use in animals-
phospholipids
-to Parenteral administration without addition of other active ingredients-
phospholipids from bovine lungs
-for the prophylaxis and therapy of respiratory distress syndrome in premature infants-
phospholipids from porcine lung
phosphorus
Phoxim
-for use in animals-
Physostigmine
Picrotoxin
Pilocarpin
Pimecrolimus
Pimobendan
-for use in animals-
Pimozide
Pinaverium bromide
Pindolol
Pioglitazone
Pipamperon
Pipecuronium Bromide
Pipemidic Acid
Pipenzolat Bromide
Piperacillin
Piperaquin
Piperazine, also known as hydrate
-as a worm-
Piperidolat
Piperoxan
Piperylon
Pipofezin
Pipoxolan
Piracetam
Pirbuterol
Pirenzepin
Piretanid
Pirfenidon
Piribedil
Piridoxilat
Pirlimycin
-for use in animals-
Piromitic acid
Piroxicam
-except for outer use-
Pirprofen
Pitavastatin and its esters
Pivampicillin
Pivmecillinam
Pixantron
Pizotifen
Plerixafor
Plicamycin
Podophyllum-emodi radix et rhizoma and their preparations
Podophyllum peltatum, radix et rhizoma and their preparations
-Excludes in homeopathic preparations for oral use produced according to the manufacturing rules 25 and 26 of the homeopathic medicinal book-
Podophylline
Podophyllinic acid and its derivatives
Podophyllotoxin
Podophyllum-emodi-and Podophyllum-peltatum-Glycosides and their derivatives
Polyestradiol
Polymyxin B and M
Poly (O-2-hydroxyethyl) starch
-for parenteral use-
Poly (styrolco-divinylbenzene) sulphonic acid (x:y)
as Aluminium, calcium, potassium and sodium salt
-except for use as auxiliary for galenic purposes in a daily dose up to 300 mg-
Polythiazid
Pomalidomide
Ponatinib
Porfimer
Posaconazole
Practolol
Pradofloxacin
-for use in animals-
Prajmalium
Pramipexole
Pramiverin
Pranoprofen
Prasterone and its esters
Prasugrel
Pravastatin
Praziquantel
-
except for application
a)
in dogs and cats, and
b)
in the ornamental fish of the orders of carp-like, Barschartige, Welsign and toothpicks with an active ingredient content of up to 20 g per pack-

Prazosin
Prednicarbat
Prednimustin
Prednisolone and its esters
Prednisone and its esters
Prednylidene and its esters
Pregabalin
Prenoxdiazine
Prenylamine
Pridinol
Prifinium hydroxide
-for use in animals-
Prilocain
-except for skin or mucosa medicines, except for the eye-
Primaquin
Primidon
Primycin
Pristinamycin
Probucol
Procain
-except for medicines to be used in the parenteral use without addition of other active substances in concentrations up to 2% for intracutaneous use in healthy skin in the context of neural therapy-
-excluding medicinal products for application to the skin, or Mucosa, except for application to the eye-
Procainamide
Procarbazin
Procaterol
Procyclidin
Progesterone
Proglumetacin
Proglumid
Proguanil
Proligeston
Prolintan
Promegestone
Promestrien
Propafenone
Propamidine
propane iodide
propanetetraphosphonic acid
-as a carrier substance for ((high) 99m Tc) technetium-
propanthelin bromide
Propicillin
propiverin
propofol
propoxyphene
Propranolol
propyl (3beta-(benzoyloxy) tropane-2alpha-carboxylate)
-for use in the eye-
propylhexedrine
Proquazon
Prostalen
-for use in animals-
Protamine
(alpha (deep) 1) -proteinase inhibitor of human beings
Prothipendyl
Protionamide
Protirelin
protocol
-except for internal use, as long as the content in the single dose does not exceed 1 mg-
Protriptylin
Proxymetacain
Prucaloprid
Pseudoephedrin
- with the exception of medicinal products for use in humans with a total amount of active substance up to 720 mg of pseudoephedrine per pack-
Pteropterin
Pulsatillae herba and its preparations
-except in homeopathic preparations For oral use manufactured in accordance with the manufacturing requirements 25 and 26 of the homeopathic medicinal book-
Pyrantel
Pyrazinamide
pyridostigmine bromide
pyrimethamine
pyriprol
-for use in animals-
Pyrithione Zinc
except for external use
a)
in a concentration up to 0.2%
b)
in a concentration of up to 1% in preparations which are rinsed off again-

Pyrithyldionmercury and its compounds
excluded
1.
2-(ethylmercurithio) benzoic acid, sodium salt (thiomersal)
a)
in tablets up to 30 mg to fight the Nosema-Seuche,
b)
up to 0.004 percent by weight in retention and wetting solutions for contact lenses
2.
2- (ethylmercurithio) benzoic acid and its salts, phenylmercuriacetate, phenylmercuriborate, phenylmercurinitrate preservative in a concentration of up to 0.002% by weight in liquid preparations, emulsions and ointments,
3.
quininmercuribisulfate in a concentration of up to 2.75% by weight in preparations in small packages Use in man for the prevention of sexually transmitted diseases,
4.
phenylmercuriborate in a concentration of up to 0.1% by weight for external use in preparations up to 50 ml or 50 g-

Quetiapin
Quinagolid
Quinapril
Quinaprilat
Quinestrol
Quinethazon
Quingestanol
Quinisocain
-except for medicines used to apply to the skin or mucosa, except for Application to the eye-
Quintiofos
Quinupristin
Rabeprazole
Racecadotril
-except in solid preparations for the symptomatic treatment of acute diarmony in adults over 18 years of age in concentrations of 100 mg per day divided form and in a total quantity of up to 1 000 mg per pack for a maximum period of application of three days, provided that the subject information and package leaflet are style="font-weight:normal; font-style:normal; text-decoration:none; ">
a)
is indicated under the contraindications that Racecadotril should not be applied to Cases associated with fever, bloody or slime stools, as they indicate the presence of invasive bacteria or other serious diseases, or occur during or after the use of antibiotics (pseudomembranous) Colitis), and
b)
is indicated in the warning signs that Racecadotril should only be used under medical prescription if it is a case of diarvation by a Acute thrust of ulcerative colitis or patients suffering from renal or hepatic insufficiency-

Racefemin
containing radionuclide-containing substances and preparations for diagnostic or therapeutic purposes
Raloxifen
Raltegravir
Ramifenazon
-for parenteral use-
-except for use in animals-
Ramipril
Ranelic acid
Ranitidine
-except in oral preparations in a A concentration of up to 75 mg per divided form and in pack sizes of up to 1 050 mg, provided that the application for adults and children is completed from 16. Year of life in the fields of application "In case of heartburn and/or acid impact" and limited to a maximum treatment duration of 14 days-
Ranolazine
Rasagilin
Rasburicase
Rauwolfia-species, their preparations and alkaloids- except in homeopathic preparations for oral use produced in accordance with the manufacturing rules 25 and 26 of the homeopathic pharmacopoeia-
Reboxetin
Regadenoson
Regorafenib
Repaglinide
Reproterol
Reserpine
Resocortol and its esters
-for use in animals-
Resorantel
Retapamulin
Reteplase
Retigabin
Retinol and its esters
-for use in humans-
-except for internal use in Preparations with a daily dose of up to 10 000 IU. -
-except for external use in preparations with a daily dose of up to 50 000 IU -
Reviparin
-for parenteral administration-
Ribavirin
Ribostamycin
Rifabutin
Rifampicin
Rifamycin
Rifaximin
Rilonacept
Rilpivirin
Riluzole
Rimazolium metilsulfate
Rimexolon
Rimonabant
Risedronic Acid
Risperidon
Ritodrin
Ritonavir
Rivaroxaban
Rivastigmine
Rizatriptan
Robenacoxib
-for use in animals-
Rocuronium bromide
Roflumilast
Rolitetracycline
Romifidin
for horses, dogs and cats-
Romiplostim
Ronidazole
-for use with Animals-
Ropinirol
Ropivacain
Rosiglitazon
Rosoxacin
Rosuvastatin
Rotigotine
Roxatidin and its esters
Roxithromycin
Rupatadin
Ruxolitinib
Sabinae oleum
Sabinae summitates-and their Preparations
except for external use in ointments-
Rufinamide
Salbutamol
Salmeterol
nitric acid
-in preparations containing acetic acid and oxalic acid-
Salverin
Samarium (153Sm) lexidronam
Santonin
Sapropterin (including its stereoisomeric mixtures)
Saquinavir
Sarafloxacin
-for use in animals-
Saralasin
Saxagliptin and its esters
Scammoniae resina and its preparations
thyroid active ingredients
sulphur hexafluoride
scilla-glycosides
scopolamine
scopoliawurzelstock and its preparations
Secale-alkaloids
Secale cornutum and its preparations
Secnidazole
Secretin
-for use as a diagnostic
Selamectin
Selegilin
selenium compounds
-except for selenium disulfide for external use in a concentration of up to 2.5 percent by weight-
-except in Internal use preparations with a daily dose of up to 50 my g selenium-
Sera and monoclonal antibodies
-for use on or in the human or animal body-
Sermorelin
Serrapeptase
Sertindol
Sertraline
Sevelamer
Sevofluran
Sibutramin
Silver nitrate
-except for external use and in eye drops for glorrhoeprophylaxis-
Silver compounds
-for use in gastrointestinal tract disorders-
Sildenafil
Silibinin-C-2 ', 3-bis (hydrogensuccinate)
-for parenteral use-
Silodosin
Simvastatin
Sincalid
Sipuleucel-T
Sirolimus
Sisomicin
Sitagliptin
Sitaxentan
Solifenacin
Somatorelin
Somatostatin
Somatropin
Sorafenib
Sotalol
Spagluminic acid
-for the treatment of seasonal rhinitis-
Sparfloxacin
Spartein
-except for external use-
Spectinomycin
Spinosad
-for use in animals-
Spiramycin and its esters
Spirapril
Spironolacton and its esters
Stanozolol and its esters
Stavudine
Steinkohlenteer and its preparations
Nitrogen monoxide
Stilbamidin
(E)-Stiripentol
Substances and preparations of substances intended to repair amenorrhoea, even if they are announced as a remedy against general, period or menstrual disorders, for use in human beings
Strandkiefernrinde and its preparations
-containing at least 50% total procyanidins, calculated as cyanidine chloride-
Streptokinase
-except for buccal or oral use-
Streptomycin
Strophanthi Semen and its preparations
Strophanthine
Strychni semen and its preparations
other than in homeopathic preparations for oral use, which are in accordance with the manufacturing rules 25 and 26 of the homeopathic medicinal book -
Strychnin
Strychnin-N-oxide
Strychninic acid
Sucralfat
Sugammadex
Sulbactam
Sulfacarbamide and its derivatives
sulfaguanidin and its derivatives
sulfanilamide and its derivatives
Sulfasalazine
Sulfinpyrazon
Sulindac
Sulindac
Suloctidil
Sulodexide
-for parenteral use-
Sulpirid
Sulproston
Sultamicillin
Sultiam
Sumatriptan
Sunitinib
Suramine-sodium < br /> Suxamethonium salts
Suxibuzon
SyrosingopinTacalcitol
Tacrin
Tacrolimus
Tadalafil
Tafamidis and its esters
Tafluprost
Talastin
Talinolol
Tamoxifen
Tamsulosin
Tasonermin
Taurolidin
Tazarotene
Tazobactam
Teduglutid
Tegafur
Teicoplanin
Telaprevir
Telavancin
Telbivudin
Telithromycin
Telmisartan
Temocapril
Temoporfin
Temozolomide
Temsirolimus
Tenecteplase
Teniposid
Tenofovir and its esters
Tenonitrozol
Tenoxicam
Tepoxalin
-for use in animals-
Terazosin
Terbinafin
-except for external use-
Terbutalin
Terfenadin
Teriflunomid
Teriparatid
Terizidon
Tertatolol
Testolacton
Testosterone and its esters
Tetrabenazine
-for the treatment of dyskinetic movement disorders-
Tetracain
Tetrachloroethylene
-except for external use -
Tetracycline
Tetracycline and its compounds
4-epi-tetracycline
Tetraisopropyl pyrophosphate
Tetr akis (2-methoxy-2-methylpropylisocyanide) copper (1 +)-tetrafluoroborate
-as a carrier substance for ((high) 99m Tc) Technetium-
Tetramisol
Tetrofosmin
Tetroxoprim
Tetrylammonium salts
Thalidomide
Thallium
Thenalidin
Theodrenaline
-for parenteral use-
Theophylline
Theophyllin-ethylenediamine < br /> Theophylline Magnesium Acetate
Theophylline (2-amino-2-methylpropan-1-ol) (1: 1)
Treatment allergens
Thevetin
Thiamazol
Thiambutosin
Thiamphenicol and its esters
Thibenzazoline
Thiobarbituric acid derivatives < br /> Thiostrepton
thiotepa
Thiouracil and its derivatives
Thyroideae glandulae siccatae and their preparations
Thyrotropin alfa
Tiabendazole
Tiagabin
Tiamulin
-for use in animals-
Tianeptin and its Ester
Tiapride
Tiaproic acid
Tiaprost
-for use in animals-
Tibolon
Ticagrelor and its esters
Ticarcillin
ticlopidin
tigecycline
tildipirosin
-for use in animals-
Tiletamine
-for use in animals-
Tilmicosin
Tiludronic acid
Timolol
Tinidazole
Tinzaparin
-for parenteral use-
Tiocarlid
Tioconazole
-except for external use-
Tioguanin
Tiomesteron
Tiopronin
Tiotixen
Tiotropium bromide and its hydrate
Tipranavir
Tiracizine
Tirofiban
Tiropramide
Tixocortol and its esters
Tizanidin
Tobramycin
Tocainid
Toceranib
-to Use in animals-
Tocofersolan and its esters
-for vitamin E deficiency due to digestive malabsorption in paediatric patients-
tolazamide
tolbutamide
tolcapone
tolciclat
tolfenamic acid
-to be used in animals-
Toliprolol
Tolmetin
tolonium chloride (toluidine blue)
-for parenteral use-
Tolperison
Tolterodin
Toltrazuril
Tolvaptan
Topiramate
Topotecan
Torasemid
Toremifen
Trabectedin
Tramadol
Trandolapril
Tranexamic acid
Transcalcifediol
Tranylcypromin
Trapidil
Travoprost
Trazodon
Treosulfan
Treprostinil
Tretamine
Tretinoin
Triacetyldiphenolisatin
Triamcinolone as well as its esters and ethers (including the acetals)
Triamcinolone acetonide and its esters
-except for use as adhesive tablets for recurrent Aphthene-
Triamteren
Triaziquon
Tribenosid
2,2,2-Tribromethanol
trichloromethiazid
trichloromethin
trichloroethylene
-except for external use-
Triclabendazole
Trifluperidol
Trifluridine
Trihexyphenidyl
Trilostan
Trimegeston
Trimetaphane Salts
Trimetazidin
Trimethadione
Trimethidinium methosulfate
Trimethoprim
Trimethylolmelamine
(2-oxo-2-(2,4,5-trimethylanilino) ethyl) azandiyl) diacetic acid
-as a carrier substance for ((high) 99m Tc) technetium
Trimetozin
Trimipramin
Triparanol
Triperiden
Triptorelin
Trofosfamid
Troleandomycin
Trolnitrate
Tromantadin
Trometamol
-for parenteral use in acid-base disorders or to Urinary alkalisation in the case of intoxications or with a content of more than 1 g of trometamol per medicinal product divided-
Tropalpin
-except preparations for internal use, to the extent that the content in the individual dose does not exceed 1 mg-
Tropenzilin
Tropicamid
Tropical benzilate
Tropisetron
-for use in chemotherapy-induced and post-operative vomation-
Trospium salts
Trovafloxacin
Tryptophan
-for the treatment of depressive Diseases-
Tuberculins, liquid or dry preparations, as well as all other preparations produced from or using tubercle bacilli
Tubocurarin
Tulathromycin
-for use in animals-
Tulobuterol
Tylosin
Tylvalosin (Acetylisovaleryltylosin) and its esters

Ulipristal and its esters
-excluding the ellaOne ® ready-to-use product for emergency contraception, which is authorised under Article 3 (1) of Regulation (EC) No 726/2004 -
Unoproston-isopropyl
Urapidil
Urethan
Urofollitropin
Urokinase
Ursodeoxycholic Acid Valaciclovir
Valdecoxib
Valdetamide
Valganciclovir
Valnemulin
Valproic Acid
Valsartan
Vancomycin
Vandetanib
Vardenafil
Vareniclin
Vasopressin and its analogues
Vecuronium bromide
Vedaprofen
-for use in animals-
Velaglucerase alfa
Vemurafenib
Venlafaxin
Verapamil
Veratri rhizoma and its preparations
-except for external use in animals and as Schneeberger snuff with a content not exceeding 3% by weight-
Veratrum alkaloids
Vernakalant
Verteporfin
Vidarabin
Vigabatrin
Vilanterol
Vildagliptin
Viloxazine
Vinblastin
Vincamin
Vincristin
Vindesin
Vinflunin
Vinorelbin
Vinpocetin
Viomycin
Viquidil
Virginiamycin
Vismodegib

Preparation from
Lidocain
and
Prilocain
-to treat primary premature ejaculation in adult males-

VoriconazolWarfarinXantocillin
Xenon
Ximelagatran
Xipamide
XylazinYohimbinic acid and its EsterZalcitabine
Zaleplon
Zanamivir
Cells of human or animal origin in fresh, frozen or dried condition, to the extent that they are intended for injection or infusion in humans
Zeranol
Ziconotid
Zidovudin
Zinc oxide for oral use in people
-except in daily doses up to 25 mg zinc-
zinc
-except
1.
for outer use
2.
in eye drop
3.
for oral application
a)
in humans, if a daily dose is indicated on containers and outer envelopes, which corresponds to a zinc content of up to 25 mg,
b)
in animals-

Ziprasidon
Zofenopril
Zolazepam
-for use in animals-
Zoledronic acid
Zolmitriptan
Zonisamide
Zopiclon
Zorubicin
Zotepin

Preparation from
Amitraz,
Fipronil
and
Methoprene
-for use in the dog-

Preparation from
Colfosceril,
1-Hexadecanol
, and
Tyloxapol

Preparation from
Emodepside
and
Praziquantel
-for use in animals-

Preparation from
Emodepside
and
Toltrazuril
-for use in animals-

Preparation from
Florfenicol
and
Flunixin
-for use in animals-

Preparation from
Flumethrin
and
Imidacloprid
-for use in cat-

Preparation from
Gimeracil,
Oteracil, and its esters
and
Tegafur

Preparation from
Imidacloprid
and
Permethrin
-for use in dogs -

Preparation from
Indoxacarb
and
Permethrin
-for use in animals-

Preparation from
Ivermectin
and
Praziquantel
-for use in the horse-


Preparation from
Lufenuron
and
Milbemycinoxim
-for use in the dog-

Preparation from
Marbofloxacin,
Clotrimazole
, and
dexamethasone acetate
-for use in the dog-


Preparation from
Metaflumizon
and
Amitraz

Preparation from
Methoprene
and
Fipronil
-for use in dogs and cats-

Preparation from
Milbemycinoxim,
Lufenuron
, and
Praziquantel
-to Application in animals-

Preparation from
Milbemycinoxim
and
Praziquantel
-for use in dogs and cats-

Preparation from
nicotinic acid
and
Laropiprant

Preparation from
Oxantel,
Praziquantel
and
Pyrantel
-for use in animals-

Preparation from
Permethrin
and
pyriproxifen
-for use in the dog-

Preparation from
xylometazolin
and
Ipratropium Bromide and its esters

Preparations of substances in pastes-, ointments-, gelatinous or similar substances as well as emulsions and solutions for introduction into the uterus and in veterinary medicine in addition to Separator and udder of the animals

Zuclopenthixol and its esters unofficial table of contents

Appendix 2 (to § 6)
Substances according to § 6

The plant contains an alphabetically ordered list of substances, with the basic use of the INN nomenclature.
1.
EnilconazolFlunixinMeclofenamic acid
2.
The following substances, as far as they are contained in medicines, which are also, or exclusively for infusion or injection, except for subcutaneous injection, determined (2-aminoethyl) dihydrogen phosphate arginine-beta-carotenboric acid bromohexinbutafosfancalcium casein-hydrolyscocarboxylaseColecalciferolcyanocobalamine-DexpanthenolDimethiconethanol-fructoseGlucoseHistidin4,5-O-hydroxyboranediyl-D-gluconic acid isoleucine potassium leucineLysine hydrochloride Magnesium MenadionMethionine Sodium riboflavin 5 '-hydrogenphosphate nicotinamide phenylalanine Procainpyridoxine retinolpalmitate sorbitol, which is listed in Table 1 of the Annex to Commission Regulation (EU) No 37/2010 of 22 June 2002. 1 December 2009 on pharmacologically active substances and their classification as regards maximum residue limits in foodstuffs of animal origin (OJ L 327, 28.12.2009, p. 1) are listed in the current version and for which this Regulation only provides for use in homeopathic veterinary medicinal products, prepared in accordance with homeopathic pharmacopoeia , the maximum concentration indicated is also maintained. Thiamine chloride hydrochloride threonintocopherol acetate toldimfos sodium tryptophanvaline valinVetrabutin.